Literature DB >> 526391

Effect of labetalol on continuous ambulatory blood pressure.

V Balasubramanian, S Mann, E B Raftery, M W Millar-Craig, D Altman.   

Abstract

1 The hypotensive action of labetalol was evaluated during 24 h by continuous intra-arterial ambulatory monitoring in 14 patients. The dose used ranged from 300--1800 mg daily. 2 The drug caused a significant reduction of systolic BP in 19 and diastolic BP in 20 of the 24 h of monitoring. Heart rate was also reduced but less markedly than BP. 3 The rapid early morning increase in BP was also effectively controlled. 4 The mild pre-waking increase in BP was not significantly reduced. 5 Labetalol treatment reduced the variation in systolic BP from the lowest observed quarter-hourly mean as compared with pre-treatment values. 6 The quarter hourly mean values were consistently smooth and revealed no sudden variations which might have resulted from postural hypotension.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 526391      PMCID: PMC1429752     

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  Continuous recording of direct arterial pressure and electrocardiogram in unrestricted man.

Authors:  W A Littler; A J Honour; P Sleight; F D Stott
Journal:  Br Med J       Date:  1972-07-08

2.  Direct arterial pressure recording in unrestricted man.

Authors:  A T Bevan; A J Honour; F H Stott
Journal:  Clin Sci       Date:  1969-04       Impact factor: 6.124

3.  New system for recording ambulatory blood pressure in man.

Authors:  M W Millar-Craig; D Hawes; J Whittington
Journal:  Med Biol Eng Comput       Date:  1978-11       Impact factor: 2.602

4.  Patterns of blood-pressure during chronic administration of postganglionic sympathetic blocking drugs for hypertension.

Authors:  A D Goldberg; E B Raftery
Journal:  Lancet       Date:  1976-11-13       Impact factor: 79.321

5.  The methodology of blood pressure recording.

Authors:  E B Raftery
Journal:  Br J Clin Pharmacol       Date:  1978-09       Impact factor: 4.335

6.  Blood pressure and heart rate and withdrawal of antihypertensive drugs.

Authors:  A D Goldberg; E B Raftery; P Wilkinson
Journal:  Br Med J       Date:  1977-05-14

Review 7.  Pharmacological effects of labetalol in man.

Authors:  D A Richards
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

8.  Circumstances attending 100 sudden deaths from coronary artery disease with coroner's necropsies.

Authors:  A Myers; H A Dewar
Journal:  Br Heart J       Date:  1975-11

9.  [Relationship between circadian rhythms and blood pressure and the pathogenesis of cerebrovascular insufficiency].

Authors:  A Agnoli; M Manfredi; L Mossuto; A Piccinelli
Journal:  Rev Neurol (Paris)       Date:  1975-09       Impact factor: 2.607

10.  Circadian variation of blood-pressure.

Authors:  M W Millar-Craig; C N Bishop; E B Raftery
Journal:  Lancet       Date:  1978-04-15       Impact factor: 79.321

View more
  7 in total

1.  A study of nadolol to determine its effect on ambulatory blood pressure over 24 hours, and during exercise testing.

Authors:  R S Hornung; B A Gould; H Kieso; E B Raftery
Journal:  Br J Clin Pharmacol       Date:  1982-07       Impact factor: 4.335

2.  Labetalol, an alpha- and beta-adrenoceptor-blocking agent: its use in therapeutics. A summary of the symposium.

Authors:  B N Prichard; D A Richards
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

3.  The effects of oxprenolol on ambulatory intra-arterial blood pressure in essential hypertension.

Authors:  M W Millar-Craig; S Mann; V Bala Subramanian; D G Altman; E B Raftery
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

4.  Magnitude and mechanisms of the antihypertensive action of labetalol, including ambulatory assessment.

Authors:  G R Bellamy; S N Hunyor; D Roffe; J Massang
Journal:  Br J Clin Pharmacol       Date:  1983-07       Impact factor: 4.335

5.  Rapid reduction of blood pressure with acute oral labetalol.

Authors:  A B Davies; V Bala Subramanian; B Gould; E B Raftery
Journal:  Br J Clin Pharmacol       Date:  1982-05       Impact factor: 4.335

6.  A comparison of labetalol and prazosin combined with atenolol in non-responders to atenolol plus hydrochlorothiazide in uncomplicated hypertension.

Authors:  E van der Veur; B S ten Berge; A J Donker; J F May; F H Schuurman; H Wesseling
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

7.  The effect of a combination of timolol, hydrochlorothiazide and amiloride on 24 hour blood pressure control using ambulatory intra-arterial monitoring.

Authors:  R S Hornung; B A Gould; H Kieso; E B Raftery
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.